Drug Trial Radar · NCT01350973
Efficacy of TAK-085 in Participants With Hypertriglyceridemia
Last checked: Nov 20, 2026Latest source record: Sep 20, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
611
Actual
Start
Nov 2009
Primary completion
Dec 2010
Study completion Dec 2010
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 10, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to determine the efficacy and safety of TAK-085, once daily (QD) or twice daily (BID), compared to ethyl eicosapentaenoate (EPA-E), three times daily (TID) in participants with hypertriglyceridemia undergoing lifestyle modification.
Conditions
- Hypertriglyceridemia
Interventions
Omega-3-acid ethyl esters 90 (TAK-085)Drug
Omega-3-acid ethyl esters 90 (TAK-085) capsules. Each one gram of fatty acid in TAK-085 contains approximately 465 mg of EPA plus 375 mg of docosahexaenoic acid-ethyl as ethyl esters.
Eicosapentaenoic acid-ethyl (EPA-E)Drug
EPA-E, 0.6 g, orally, three-times daily for up to 12 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline in Triglyceride Level at the Final VisitTime frame: Baseline and 12 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.